Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for TCF3_MYOG
Z-value: 3.03
Motif logo
Transcription factors associated with TCF3_MYOG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TCF3
|
ENSG00000071564.10 | transcription factor 3 |
|
MYOG
|
ENSG00000122180.4 | myogenin |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MYOG | hg19_v2_chr1_-_203055129_203055164 | 0.30 | 9.2e-02 | Click! |
| TCF3 | hg19_v2_chr19_-_1652575_1652621 | -0.03 | 8.7e-01 | Click! |
Activity profile of TCF3_MYOG motif
Sorted Z-values of TCF3_MYOG motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr9_-_35689900 | 13.70 |
ENST00000378300.5
ENST00000329305.2 ENST00000360958.2 |
TPM2
|
tropomyosin 2 (beta) |
| chr19_-_45826125 | 12.92 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
| chr2_+_220283091 | 9.94 |
ENST00000373960.3
|
DES
|
desmin |
| chr4_+_114214125 | 8.41 |
ENST00000509550.1
|
ANK2
|
ankyrin 2, neuronal |
| chr3_-_195310802 | 8.27 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
| chr8_-_33455268 | 7.95 |
ENST00000522982.1
|
DUSP26
|
dual specificity phosphatase 26 (putative) |
| chr22_+_31489344 | 7.90 |
ENST00000404574.1
|
SMTN
|
smoothelin |
| chr4_+_113970772 | 7.40 |
ENST00000504454.1
ENST00000394537.3 ENST00000357077.4 ENST00000264366.6 |
ANK2
|
ankyrin 2, neuronal |
| chr1_+_78354330 | 7.36 |
ENST00000440324.1
|
NEXN
|
nexilin (F actin binding protein) |
| chr2_-_152590946 | 7.34 |
ENST00000172853.10
|
NEB
|
nebulin |
| chr11_-_119252359 | 7.16 |
ENST00000455332.2
|
USP2
|
ubiquitin specific peptidase 2 |
| chr11_-_63933504 | 7.10 |
ENST00000255681.6
|
MACROD1
|
MACRO domain containing 1 |
| chr1_+_78354175 | 7.04 |
ENST00000401035.3
ENST00000457030.1 ENST00000330010.8 |
NEXN
|
nexilin (F actin binding protein) |
| chr16_+_55522536 | 7.00 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chr1_+_172422026 | 6.92 |
ENST00000367725.4
|
C1orf105
|
chromosome 1 open reading frame 105 |
| chr2_-_220436248 | 6.84 |
ENST00000265318.4
|
OBSL1
|
obscurin-like 1 |
| chr3_+_69788576 | 6.77 |
ENST00000352241.4
ENST00000448226.2 |
MITF
|
microphthalmia-associated transcription factor |
| chrX_-_33357558 | 6.60 |
ENST00000288447.4
|
DMD
|
dystrophin |
| chr2_-_220435963 | 6.49 |
ENST00000373876.1
ENST00000404537.1 ENST00000603926.1 ENST00000373873.4 ENST00000289656.3 |
OBSL1
|
obscurin-like 1 |
| chr2_-_75426826 | 6.46 |
ENST00000305249.5
|
TACR1
|
tachykinin receptor 1 |
| chr1_+_78354297 | 6.45 |
ENST00000334785.7
|
NEXN
|
nexilin (F actin binding protein) |
| chr10_+_123951957 | 6.43 |
ENST00000514539.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
| chr8_-_41522779 | 6.38 |
ENST00000522231.1
ENST00000314214.8 ENST00000348036.4 ENST00000457297.1 ENST00000522543.1 |
ANK1
|
ankyrin 1, erythrocytic |
| chr1_+_78354243 | 6.26 |
ENST00000294624.8
|
NEXN
|
nexilin (F actin binding protein) |
| chr6_+_41021027 | 6.26 |
ENST00000244669.2
|
APOBEC2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
| chr17_-_10452929 | 6.13 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
| chr16_+_7382745 | 6.12 |
ENST00000436368.2
ENST00000311745.5 ENST00000355637.4 ENST00000340209.4 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr17_-_41132088 | 6.11 |
ENST00000591916.1
ENST00000451885.2 ENST00000454303.1 |
PTGES3L
PTGES3L-AARSD1
|
prostaglandin E synthase 3 (cytosolic)-like PTGES3L-AARSD1 readthrough |
| chr3_-_87039662 | 5.84 |
ENST00000494229.1
|
VGLL3
|
vestigial like 3 (Drosophila) |
| chr11_-_119252425 | 5.62 |
ENST00000260187.2
|
USP2
|
ubiquitin specific peptidase 2 |
| chrX_-_103087136 | 5.39 |
ENST00000243298.2
|
RAB9B
|
RAB9B, member RAS oncogene family |
| chr2_+_220299547 | 5.34 |
ENST00000312358.7
|
SPEG
|
SPEG complex locus |
| chr5_+_80529104 | 5.33 |
ENST00000254035.4
ENST00000511719.1 ENST00000437669.1 ENST00000424301.2 ENST00000505060.1 |
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric) |
| chr7_+_123295861 | 5.27 |
ENST00000458573.2
ENST00000456238.2 |
LMOD2
|
leiomodin 2 (cardiac) |
| chrX_+_70521584 | 5.25 |
ENST00000373829.3
ENST00000538820.1 |
ITGB1BP2
|
integrin beta 1 binding protein (melusin) 2 |
| chr17_+_65040678 | 5.23 |
ENST00000226021.3
|
CACNG1
|
calcium channel, voltage-dependent, gamma subunit 1 |
| chr2_+_27505260 | 5.19 |
ENST00000380075.2
ENST00000296098.4 |
TRIM54
|
tripartite motif containing 54 |
| chr1_-_201391149 | 5.17 |
ENST00000555948.1
ENST00000556362.1 |
TNNI1
|
troponin I type 1 (skeletal, slow) |
| chr3_-_87040233 | 5.14 |
ENST00000398399.2
|
VGLL3
|
vestigial like 3 (Drosophila) |
| chr2_+_103236004 | 5.13 |
ENST00000233969.2
|
SLC9A2
|
solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 |
| chr6_+_150464155 | 5.12 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| chr4_-_186456652 | 5.10 |
ENST00000284767.5
ENST00000284770.5 |
PDLIM3
|
PDZ and LIM domain 3 |
| chr19_+_35521699 | 5.03 |
ENST00000415950.3
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr11_+_1940786 | 5.01 |
ENST00000278317.6
ENST00000381561.4 ENST00000381548.3 ENST00000360603.3 ENST00000381549.3 |
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr2_+_170366203 | 4.98 |
ENST00000284669.1
|
KLHL41
|
kelch-like family member 41 |
| chr11_+_1942580 | 4.95 |
ENST00000381558.1
|
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr3_-_69171739 | 4.94 |
ENST00000489031.1
|
LMOD3
|
leiomodin 3 (fetal) |
| chr6_+_129204337 | 4.90 |
ENST00000421865.2
|
LAMA2
|
laminin, alpha 2 |
| chr19_-_46285646 | 4.86 |
ENST00000458663.2
|
DMPK
|
dystrophia myotonica-protein kinase |
| chr5_+_126626498 | 4.85 |
ENST00000503335.2
ENST00000508365.1 ENST00000418761.2 ENST00000274473.6 |
MEGF10
|
multiple EGF-like-domains 10 |
| chr4_-_186456766 | 4.74 |
ENST00000284771.6
|
PDLIM3
|
PDZ and LIM domain 3 |
| chr8_+_98788057 | 4.72 |
ENST00000517924.1
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta |
| chr19_-_46285736 | 4.71 |
ENST00000291270.4
ENST00000447742.2 ENST00000354227.5 |
DMPK
|
dystrophia myotonica-protein kinase |
| chr8_-_41522719 | 4.61 |
ENST00000335651.6
|
ANK1
|
ankyrin 1, erythrocytic |
| chr9_+_134165063 | 4.57 |
ENST00000372264.3
|
PPAPDC3
|
phosphatidic acid phosphatase type 2 domain containing 3 |
| chr17_+_71161140 | 4.57 |
ENST00000357585.2
|
SSTR2
|
somatostatin receptor 2 |
| chr9_-_35685452 | 4.45 |
ENST00000607559.1
|
TPM2
|
tropomyosin 2 (beta) |
| chr19_+_35521572 | 4.42 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr9_+_102584128 | 4.39 |
ENST00000338488.4
ENST00000395097.2 |
NR4A3
|
nuclear receptor subfamily 4, group A, member 3 |
| chr10_+_103348031 | 4.37 |
ENST00000370151.4
ENST00000370147.1 ENST00000370148.2 |
DPCD
|
deleted in primary ciliary dyskinesia homolog (mouse) |
| chr5_+_148960931 | 4.29 |
ENST00000333677.6
|
ARHGEF37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
| chr4_-_101111615 | 4.28 |
ENST00000273990.2
|
DDIT4L
|
DNA-damage-inducible transcript 4-like |
| chr8_+_98788003 | 4.27 |
ENST00000521545.2
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta |
| chr15_-_40633101 | 4.18 |
ENST00000559313.1
|
C15orf52
|
chromosome 15 open reading frame 52 |
| chr22_-_36013368 | 4.08 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
| chr12_+_121088291 | 4.08 |
ENST00000351200.2
|
CABP1
|
calcium binding protein 1 |
| chr3_+_148709128 | 4.08 |
ENST00000345003.4
ENST00000296048.6 ENST00000483267.1 |
GYG1
|
glycogenin 1 |
| chr15_-_94614049 | 4.05 |
ENST00000556447.1
ENST00000555772.1 |
CTD-3049M7.1
|
CTD-3049M7.1 |
| chr5_+_137774706 | 4.05 |
ENST00000378339.2
ENST00000254901.5 ENST00000506158.1 |
REEP2
|
receptor accessory protein 2 |
| chr1_-_171621815 | 3.99 |
ENST00000037502.6
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response |
| chr1_-_201915590 | 3.99 |
ENST00000367288.4
|
LMOD1
|
leiomodin 1 (smooth muscle) |
| chr11_+_111783450 | 3.98 |
ENST00000537382.1
|
HSPB2
|
Homo sapiens heat shock 27kDa protein 2 (HSPB2), mRNA. |
| chr17_+_47653178 | 3.91 |
ENST00000328741.5
|
NXPH3
|
neurexophilin 3 |
| chr3_+_159570722 | 3.89 |
ENST00000482804.1
|
SCHIP1
|
schwannomin interacting protein 1 |
| chr22_-_36018569 | 3.88 |
ENST00000419229.1
ENST00000406324.1 |
MB
|
myoglobin |
| chr11_+_1860832 | 3.87 |
ENST00000252898.7
|
TNNI2
|
troponin I type 2 (skeletal, fast) |
| chr9_-_13165457 | 3.83 |
ENST00000542239.1
ENST00000538841.1 ENST00000433359.2 |
MPDZ
|
multiple PDZ domain protein |
| chr1_-_165414414 | 3.83 |
ENST00000359842.5
|
RXRG
|
retinoid X receptor, gamma |
| chr6_-_75915757 | 3.80 |
ENST00000322507.8
|
COL12A1
|
collagen, type XII, alpha 1 |
| chr7_+_128470431 | 3.79 |
ENST00000325888.8
ENST00000346177.6 |
FLNC
|
filamin C, gamma |
| chr16_+_30383613 | 3.71 |
ENST00000568749.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr4_-_140005341 | 3.68 |
ENST00000379549.2
ENST00000512627.1 |
ELF2
|
E74-like factor 2 (ets domain transcription factor) |
| chrX_-_99665262 | 3.68 |
ENST00000373034.4
ENST00000255531.7 |
PCDH19
|
protocadherin 19 |
| chr10_+_18689637 | 3.66 |
ENST00000377315.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr3_+_148709310 | 3.64 |
ENST00000484197.1
ENST00000492285.2 ENST00000461191.1 |
GYG1
|
glycogenin 1 |
| chr1_-_33338076 | 3.64 |
ENST00000496770.1
|
FNDC5
|
fibronectin type III domain containing 5 |
| chr19_-_49658387 | 3.62 |
ENST00000595625.1
|
HRC
|
histidine rich calcium binding protein |
| chrX_-_128788914 | 3.61 |
ENST00000429967.1
ENST00000307484.6 |
APLN
|
apelin |
| chr19_-_49658641 | 3.60 |
ENST00000252825.4
|
HRC
|
histidine rich calcium binding protein |
| chr7_-_120497178 | 3.58 |
ENST00000441017.1
ENST00000424710.1 ENST00000433758.1 |
TSPAN12
|
tetraspanin 12 |
| chr19_-_47137942 | 3.46 |
ENST00000300873.4
|
GNG8
|
guanine nucleotide binding protein (G protein), gamma 8 |
| chr13_-_114107839 | 3.46 |
ENST00000375418.3
|
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
| chr17_+_47653471 | 3.43 |
ENST00000513748.1
|
NXPH3
|
neurexophilin 3 |
| chr9_+_134165195 | 3.39 |
ENST00000372261.1
|
PPAPDC3
|
phosphatidic acid phosphatase type 2 domain containing 3 |
| chr4_-_177190364 | 3.38 |
ENST00000296525.3
|
ASB5
|
ankyrin repeat and SOCS box containing 5 |
| chr5_-_146833803 | 3.37 |
ENST00000512722.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
| chr14_-_89021077 | 3.35 |
ENST00000556564.1
|
PTPN21
|
protein tyrosine phosphatase, non-receptor type 21 |
| chr6_+_17281573 | 3.35 |
ENST00000379052.5
|
RBM24
|
RNA binding motif protein 24 |
| chr17_+_45286706 | 3.32 |
ENST00000393450.1
ENST00000572303.1 |
MYL4
|
myosin, light chain 4, alkali; atrial, embryonic |
| chr1_+_13910479 | 3.30 |
ENST00000509009.1
|
PDPN
|
podoplanin |
| chr7_-_150675372 | 3.29 |
ENST00000262186.5
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
| chr17_+_39421591 | 3.28 |
ENST00000391355.1
|
KRTAP9-6
|
keratin associated protein 9-6 |
| chr22_+_21369316 | 3.25 |
ENST00000413302.2
ENST00000402329.3 ENST00000336296.2 ENST00000401443.1 ENST00000443995.3 |
P2RX6
|
purinergic receptor P2X, ligand-gated ion channel, 6 |
| chr17_-_41738931 | 3.25 |
ENST00000329168.3
ENST00000549132.1 |
MEOX1
|
mesenchyme homeobox 1 |
| chr1_+_13910194 | 3.25 |
ENST00000376057.4
ENST00000510906.1 |
PDPN
|
podoplanin |
| chr11_-_47470703 | 3.22 |
ENST00000298854.2
|
RAPSN
|
receptor-associated protein of the synapse |
| chr15_-_44487408 | 3.22 |
ENST00000402883.1
ENST00000417257.1 |
FRMD5
|
FERM domain containing 5 |
| chr7_+_70597109 | 3.21 |
ENST00000333538.5
|
WBSCR17
|
Williams-Beuren syndrome chromosome region 17 |
| chr3_+_42727011 | 3.21 |
ENST00000287777.4
|
KLHL40
|
kelch-like family member 40 |
| chr1_-_27339317 | 3.18 |
ENST00000289166.5
|
FAM46B
|
family with sequence similarity 46, member B |
| chr19_+_35521616 | 3.17 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr3_-_39234074 | 3.16 |
ENST00000340369.3
ENST00000421646.1 ENST00000396251.1 |
XIRP1
|
xin actin-binding repeat containing 1 |
| chr3_+_49059038 | 3.11 |
ENST00000451378.2
|
NDUFAF3
|
NADH dehydrogenase (ubiquinone) complex I, assembly factor 3 |
| chr11_-_2170786 | 3.11 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr7_+_116166331 | 3.07 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr3_+_35681081 | 3.04 |
ENST00000428373.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr13_-_36705425 | 3.03 |
ENST00000255448.4
ENST00000360631.3 ENST00000379892.4 |
DCLK1
|
doublecortin-like kinase 1 |
| chr19_-_46272462 | 3.02 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
| chrX_+_100474906 | 3.02 |
ENST00000541709.1
|
DRP2
|
dystrophin related protein 2 |
| chr17_-_62066769 | 3.02 |
ENST00000577329.1
|
CTC-264K15.6
|
CTC-264K15.6 |
| chr8_+_22411931 | 3.00 |
ENST00000523402.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
| chr4_-_140005443 | 2.99 |
ENST00000510408.1
ENST00000420916.2 ENST00000358635.3 |
ELF2
|
E74-like factor 2 (ets domain transcription factor) |
| chr18_+_33877654 | 2.98 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr3_+_8775466 | 2.97 |
ENST00000343849.2
ENST00000397368.2 |
CAV3
|
caveolin 3 |
| chr17_+_45286387 | 2.96 |
ENST00000572316.1
ENST00000354968.1 ENST00000576874.1 ENST00000536623.2 |
MYL4
|
myosin, light chain 4, alkali; atrial, embryonic |
| chr19_-_35626104 | 2.95 |
ENST00000310123.3
ENST00000392225.3 |
LGI4
|
leucine-rich repeat LGI family, member 4 |
| chr15_+_74466744 | 2.94 |
ENST00000560862.1
ENST00000395118.1 |
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
| chrX_-_84634737 | 2.93 |
ENST00000262753.4
|
POF1B
|
premature ovarian failure, 1B |
| chr19_+_11658655 | 2.93 |
ENST00000588935.1
|
CNN1
|
calponin 1, basic, smooth muscle |
| chr17_+_39388700 | 2.92 |
ENST00000411528.2
|
KRTAP9-3
|
keratin associated protein 9-3 |
| chrX_+_100474711 | 2.92 |
ENST00000402866.1
|
DRP2
|
dystrophin related protein 2 |
| chr10_-_79398250 | 2.92 |
ENST00000286627.5
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr11_-_1606513 | 2.92 |
ENST00000382171.2
|
KRTAP5-1
|
keratin associated protein 5-1 |
| chr19_-_42916499 | 2.90 |
ENST00000601189.1
ENST00000599211.1 |
LIPE
|
lipase, hormone-sensitive |
| chr4_-_186696425 | 2.89 |
ENST00000430503.1
ENST00000319454.6 ENST00000450341.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr17_+_27920486 | 2.88 |
ENST00000394859.3
|
ANKRD13B
|
ankyrin repeat domain 13B |
| chr11_-_111783919 | 2.88 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
| chr13_+_31480328 | 2.87 |
ENST00000380482.4
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis |
| chr17_-_27949911 | 2.87 |
ENST00000492276.2
ENST00000345068.5 ENST00000584602.1 |
CORO6
|
coronin 6 |
| chr2_-_179659669 | 2.87 |
ENST00000436599.1
|
TTN
|
titin |
| chr12_-_70093190 | 2.87 |
ENST00000330891.5
|
BEST3
|
bestrophin 3 |
| chr14_+_32964258 | 2.85 |
ENST00000556638.1
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chrX_-_71933888 | 2.84 |
ENST00000373542.4
ENST00000339490.3 ENST00000541944.1 ENST00000373539.3 ENST00000373545.3 |
PHKA1
|
phosphorylase kinase, alpha 1 (muscle) |
| chr21_-_39870339 | 2.82 |
ENST00000429727.2
ENST00000398905.1 ENST00000398907.1 ENST00000453032.2 ENST00000288319.7 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
| chr7_+_116165754 | 2.82 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr1_-_84464780 | 2.80 |
ENST00000260505.8
|
TTLL7
|
tubulin tyrosine ligase-like family, member 7 |
| chr7_-_27224795 | 2.80 |
ENST00000006015.3
|
HOXA11
|
homeobox A11 |
| chr2_-_183291741 | 2.79 |
ENST00000351439.5
ENST00000409365.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
| chr22_+_41777927 | 2.78 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
| chr22_+_26138108 | 2.74 |
ENST00000536101.1
ENST00000335473.7 ENST00000407587.2 |
MYO18B
|
myosin XVIIIB |
| chr2_+_233390863 | 2.74 |
ENST00000449596.1
ENST00000543200.1 |
CHRND
|
cholinergic receptor, nicotinic, delta (muscle) |
| chr17_-_62050278 | 2.73 |
ENST00000578147.1
ENST00000435607.1 |
SCN4A
|
sodium channel, voltage-gated, type IV, alpha subunit |
| chr3_-_165555200 | 2.73 |
ENST00000479451.1
ENST00000540653.1 ENST00000488954.1 ENST00000264381.3 |
BCHE
|
butyrylcholinesterase |
| chr3_+_121311966 | 2.72 |
ENST00000338040.4
|
FBXO40
|
F-box protein 40 |
| chr2_+_85981008 | 2.71 |
ENST00000306279.3
|
ATOH8
|
atonal homolog 8 (Drosophila) |
| chr7_+_20370300 | 2.71 |
ENST00000537992.1
|
ITGB8
|
integrin, beta 8 |
| chr7_-_27224842 | 2.71 |
ENST00000517402.1
|
HOXA11
|
homeobox A11 |
| chr1_-_17304771 | 2.71 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
| chr14_-_81916501 | 2.68 |
ENST00000555001.1
|
RP11-299L17.3
|
RP11-299L17.3 |
| chr5_-_59064458 | 2.67 |
ENST00000502575.1
ENST00000507116.1 |
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
| chrX_-_152939252 | 2.67 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
| chr4_+_169418255 | 2.65 |
ENST00000505667.1
ENST00000511948.1 |
PALLD
|
palladin, cytoskeletal associated protein |
| chr17_-_41739283 | 2.65 |
ENST00000393661.2
ENST00000318579.4 |
MEOX1
|
mesenchyme homeobox 1 |
| chr15_-_48937982 | 2.65 |
ENST00000316623.5
|
FBN1
|
fibrillin 1 |
| chrX_+_100474763 | 2.63 |
ENST00000395209.3
|
DRP2
|
dystrophin related protein 2 |
| chr3_-_99833333 | 2.62 |
ENST00000354552.3
ENST00000331335.5 ENST00000398326.2 |
FILIP1L
|
filamin A interacting protein 1-like |
| chr8_-_72274095 | 2.61 |
ENST00000303824.7
|
EYA1
|
eyes absent homolog 1 (Drosophila) |
| chr4_-_41216492 | 2.61 |
ENST00000503503.1
ENST00000509446.1 ENST00000503264.1 ENST00000508707.1 ENST00000508593.1 |
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
| chr7_+_98246588 | 2.61 |
ENST00000265634.3
|
NPTX2
|
neuronal pentraxin II |
| chr11_-_47470682 | 2.60 |
ENST00000529341.1
ENST00000352508.3 |
RAPSN
|
receptor-associated protein of the synapse |
| chr20_-_30433396 | 2.59 |
ENST00000375978.3
|
FOXS1
|
forkhead box S1 |
| chr14_+_32963433 | 2.57 |
ENST00000554410.1
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr8_+_86351056 | 2.57 |
ENST00000285381.2
|
CA3
|
carbonic anhydrase III, muscle specific |
| chr9_+_95997205 | 2.56 |
ENST00000411624.1
|
WNK2
|
WNK lysine deficient protein kinase 2 |
| chr2_+_205410723 | 2.56 |
ENST00000358768.2
ENST00000351153.1 ENST00000349953.3 |
PARD3B
|
par-3 family cell polarity regulator beta |
| chr9_+_133259836 | 2.54 |
ENST00000455439.2
|
HMCN2
|
hemicentin 2 |
| chr3_-_52868931 | 2.53 |
ENST00000486659.1
|
MUSTN1
|
musculoskeletal, embryonic nuclear protein 1 |
| chr10_-_13043697 | 2.53 |
ENST00000378825.3
|
CCDC3
|
coiled-coil domain containing 3 |
| chr1_+_153600869 | 2.53 |
ENST00000292169.1
ENST00000368696.3 ENST00000436839.1 |
S100A1
|
S100 calcium binding protein A1 |
| chr9_-_123239632 | 2.52 |
ENST00000416449.1
|
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2 |
| chr2_+_56411131 | 2.52 |
ENST00000407595.2
|
CCDC85A
|
coiled-coil domain containing 85A |
| chr12_-_70093065 | 2.50 |
ENST00000553096.1
|
BEST3
|
bestrophin 3 |
| chr17_-_53800217 | 2.50 |
ENST00000424486.2
|
TMEM100
|
transmembrane protein 100 |
| chr11_-_47470591 | 2.50 |
ENST00000524487.1
|
RAPSN
|
receptor-associated protein of the synapse |
| chr14_+_105781102 | 2.50 |
ENST00000547217.1
|
PACS2
|
phosphofurin acidic cluster sorting protein 2 |
| chr6_-_105585022 | 2.49 |
ENST00000314641.5
|
BVES
|
blood vessel epicardial substance |
| chrX_+_100333709 | 2.49 |
ENST00000372930.4
|
TMEM35
|
transmembrane protein 35 |
| chr8_-_144512576 | 2.47 |
ENST00000333480.2
|
MAFA
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A |
| chr19_-_42498369 | 2.47 |
ENST00000302102.5
ENST00000545399.1 |
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
| chr7_+_72848092 | 2.46 |
ENST00000344575.3
|
FZD9
|
frizzled family receptor 9 |
| chr14_-_38725573 | 2.46 |
ENST00000342213.2
|
CLEC14A
|
C-type lectin domain family 14, member A |
| chr19_-_46272106 | 2.44 |
ENST00000560168.1
|
SIX5
|
SIX homeobox 5 |
| chr7_-_32110451 | 2.44 |
ENST00000396191.1
ENST00000396182.2 |
PDE1C
|
phosphodiesterase 1C, calmodulin-dependent 70kDa |
| chr19_-_6502341 | 2.43 |
ENST00000598006.1
ENST00000601152.1 |
TUBB4A
|
tubulin, beta 4A class IVa |
| chr14_+_72399114 | 2.42 |
ENST00000553525.1
ENST00000555571.1 |
RGS6
|
regulator of G-protein signaling 6 |
| chr11_-_123525648 | 2.42 |
ENST00000527836.1
|
SCN3B
|
sodium channel, voltage-gated, type III, beta subunit |
| chr17_-_15168624 | 2.40 |
ENST00000312280.3
ENST00000494511.1 ENST00000580584.1 |
PMP22
|
peripheral myelin protein 22 |
| chr10_+_88428206 | 2.40 |
ENST00000429277.2
ENST00000458213.2 ENST00000352360.5 |
LDB3
|
LIM domain binding 3 |
| chr19_-_49222956 | 2.38 |
ENST00000599703.1
ENST00000318083.6 ENST00000419611.1 ENST00000377367.3 |
MAMSTR
|
MEF2 activating motif and SAP domain containing transcriptional regulator |
| chr1_+_110655050 | 2.36 |
ENST00000334179.3
|
UBL4B
|
ubiquitin-like 4B |
Network of associatons between targets according to the STRING database.
First level regulatory network of TCF3_MYOG
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 15.8 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
| 3.2 | 12.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 2.8 | 8.3 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 2.4 | 7.2 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 2.2 | 6.5 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 2.1 | 8.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 2.0 | 2.0 | GO:0072098 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 2.0 | 7.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 2.0 | 5.9 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.8 | 1.8 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 1.7 | 3.4 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 1.6 | 4.8 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 1.5 | 3.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 1.5 | 7.3 | GO:0007525 | somatic muscle development(GO:0007525) |
| 1.4 | 15.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 1.4 | 5.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.3 | 10.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.3 | 6.5 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) operant conditioning(GO:0035106) |
| 1.3 | 19.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 1.2 | 31.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 1.2 | 3.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 1.1 | 4.4 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 1.1 | 3.3 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 1.1 | 6.5 | GO:0018032 | protein amidation(GO:0018032) |
| 1.1 | 18.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 1.0 | 3.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 1.0 | 4.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 1.0 | 5.9 | GO:0061056 | somite specification(GO:0001757) sclerotome development(GO:0061056) |
| 1.0 | 7.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.9 | 4.6 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.9 | 64.8 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.9 | 2.7 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.9 | 13.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.9 | 5.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.8 | 1.7 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
| 0.8 | 2.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
| 0.8 | 2.5 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.8 | 4.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.8 | 0.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.7 | 3.7 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.7 | 0.7 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.7 | 7.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 | 3.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.7 | 5.4 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.7 | 4.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.7 | 7.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.6 | 1.9 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.6 | 12.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.6 | 3.2 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 0.6 | 1.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.6 | 3.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 0.6 | 2.5 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.6 | 5.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.6 | 1.7 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.6 | 2.3 | GO:0046882 | negative regulation of B cell differentiation(GO:0045578) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.6 | 2.2 | GO:0018963 | insecticide metabolic process(GO:0017143) phthalate metabolic process(GO:0018963) |
| 0.5 | 1.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.5 | 12.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.5 | 7.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.5 | 6.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.5 | 2.1 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.5 | 4.9 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.5 | 3.9 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.5 | 2.4 | GO:0015862 | uridine transport(GO:0015862) |
| 0.5 | 1.4 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.5 | 1.4 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.5 | 5.5 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.5 | 1.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.5 | 3.2 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.5 | 5.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.4 | 0.4 | GO:2000981 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.4 | 1.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.4 | 11.0 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.4 | 3.5 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.4 | 6.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.4 | 4.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.4 | 1.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.4 | 0.8 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.4 | 0.8 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.4 | 2.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.4 | 1.6 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
| 0.4 | 1.6 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.4 | 2.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.4 | 2.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 | 2.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.4 | 1.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.4 | 4.6 | GO:1903416 | response to glycoside(GO:1903416) |
| 0.4 | 6.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.4 | 1.5 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.4 | 1.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.4 | 2.1 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.3 | 1.0 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.3 | 1.7 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.3 | 3.4 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.3 | 1.7 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.3 | 2.0 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.3 | 1.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 0.3 | 1.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 | 5.6 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.3 | 1.2 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.3 | 3.4 | GO:0072564 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 0.3 | 1.9 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.3 | 4.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.3 | 2.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.3 | 4.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.3 | 3.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 0.3 | 4.3 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
| 0.3 | 1.1 | GO:0060775 | cardiac right atrium morphogenesis(GO:0003213) chemoattraction of serotonergic neuron axon(GO:0036517) mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) chemoattraction of axon(GO:0061642) negative regulation of cell proliferation in midbrain(GO:1904934) planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation(GO:1904955) |
| 0.3 | 3.1 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 | 0.8 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.3 | 0.8 | GO:0097212 | cadmium ion homeostasis(GO:0055073) lysosomal membrane organization(GO:0097212) negative regulation of hydrogen peroxide catabolic process(GO:2000296) regulation of oxygen metabolic process(GO:2000374) |
| 0.3 | 2.7 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.3 | 1.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.3 | 0.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.3 | 1.6 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 0.3 | 1.3 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.3 | 1.6 | GO:0030047 | actin modification(GO:0030047) |
| 0.3 | 3.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.3 | 5.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 | 1.5 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.3 | 1.8 | GO:1990539 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 | 1.2 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.2 | 1.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.2 | 1.0 | GO:0035854 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.2 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.2 | 1.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 | 3.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 | 1.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 0.9 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.2 | 2.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.2 | 1.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.2 | 0.9 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.2 | 0.5 | GO:1902744 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.2 | 1.8 | GO:1905024 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
| 0.2 | 6.4 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.2 | 1.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.2 | 2.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.2 | 2.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.2 | 6.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.2 | 0.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.2 | 0.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 0.6 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.2 | 2.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.2 | 1.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.2 | 1.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 | 3.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.2 | 0.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.2 | 6.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 2.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 1.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 0.9 | GO:0035802 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.2 | 0.6 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 | 1.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.2 | 0.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 | 7.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 2.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 2.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.2 | 1.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.2 | 0.9 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.2 | 2.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 | 8.9 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 0.7 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.2 | 4.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 | 1.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.2 | 1.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 | 3.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 1.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.2 | 1.8 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.2 | 2.9 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.2 | 0.8 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.2 | 2.3 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 | 3.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.2 | 2.8 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.2 | 0.8 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.2 | 1.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 0.8 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.2 | 1.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.2 | 7.1 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.2 | 0.5 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.1 | 2.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 2.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 2.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 1.3 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) positive regulation of microtubule nucleation(GO:0090063) |
| 0.1 | 6.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.1 | 0.8 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 | 0.3 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.1 | 4.0 | GO:0030239 | myofibril assembly(GO:0030239) |
| 0.1 | 1.1 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
| 0.1 | 2.6 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 | 2.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 0.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 | 5.9 | GO:0031111 | negative regulation of microtubule depolymerization(GO:0007026) negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
| 0.1 | 0.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 | 1.6 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.1 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 0.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.1 | 1.6 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.1 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 1.5 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 2.4 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 0.6 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.1 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.1 | 0.6 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.1 | 2.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 4.6 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 1.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.1 | 1.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.1 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 0.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 | 1.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 | 1.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 1.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 | 3.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.3 | GO:0043488 | regulation of RNA stability(GO:0043487) regulation of mRNA stability(GO:0043488) |
| 0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 1.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 | 0.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 | 0.3 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.1 | 0.1 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.1 | 0.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 3.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 1.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.2 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.1 | 1.6 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.1 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 3.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 | 6.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
| 0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 7.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 1.0 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.1 | 0.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 | 0.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.1 | 0.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 1.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 2.5 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.1 | 3.6 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 1.7 | GO:0009629 | response to gravity(GO:0009629) |
| 0.1 | 1.2 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 3.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 4.0 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.1 | 0.7 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.7 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.1 | 1.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 | 1.0 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 1.0 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 1.0 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 6.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.4 | GO:0046959 | habituation(GO:0046959) |
| 0.1 | 0.4 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 1.4 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.1 | 3.7 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.1 | 1.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 1.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) presynaptic membrane assembly(GO:0097105) |
| 0.1 | 0.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 9.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.2 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.1 | 0.7 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.1 | 0.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 0.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.1 | 0.4 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.1 | 1.3 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 0.5 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.1 | 0.4 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 | 0.3 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.1 | 0.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 2.7 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 0.4 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 0.7 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 1.2 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.1 | 0.6 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 1.0 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.1 | 2.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 2.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.1 | 2.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 1.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.1 | 5.7 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 1.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.1 | 0.3 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 | 0.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.1 | 0.7 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 | 0.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 2.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.3 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 1.2 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 | 3.0 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 1.2 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 2.0 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.1 | 0.2 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
| 0.1 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 | 0.9 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.1 | 1.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.1 | 0.4 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.1 | 1.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
| 0.1 | 0.2 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.1 | 1.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 15.4 | GO:0006936 | muscle contraction(GO:0006936) |
| 0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.9 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.1 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.1 | 0.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 1.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.1 | 1.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 5.2 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 1.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.1 | 8.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.7 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 1.3 | GO:0007422 | peripheral nervous system development(GO:0007422) |
| 0.1 | 0.2 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 0.7 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 0.0 | 5.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 1.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 1.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 | 1.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.0 | 0.1 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.0 | 2.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 1.0 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
| 0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 0.1 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.0 | 1.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.0 | 1.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.9 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 | 1.8 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.0 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 | 0.7 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 0.0 | 0.2 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 | 0.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.0 | 2.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.0 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 2.5 | GO:0008306 | associative learning(GO:0008306) |
| 0.0 | 0.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.0 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.0 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 | 0.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 1.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.0 | 1.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 | 0.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.0 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 1.8 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.0 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.5 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 1.9 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 | 1.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.0 | 2.5 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
| 0.0 | 0.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 0.0 | 3.2 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
| 0.0 | 8.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 2.3 | GO:0051588 | regulation of neurotransmitter secretion(GO:0046928) regulation of neurotransmitter transport(GO:0051588) |
| 0.0 | 5.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.0 | 9.7 | GO:0042692 | muscle cell differentiation(GO:0042692) |
| 0.0 | 0.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.0 | 0.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.0 | 0.1 | GO:0046022 | positive regulation of transcription during mitosis(GO:0045897) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 | 0.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 1.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.0 | 1.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.0 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 4.5 | GO:0001764 | neuron migration(GO:0001764) |
| 0.0 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
| 0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.0 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 1.3 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 0.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.0 | 3.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 1.3 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
| 0.0 | 2.9 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 0.0 | 0.4 | GO:0070997 | neuron death(GO:0070997) |
| 0.0 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 0.8 | GO:0036258 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) |
| 0.0 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.5 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.0 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.0 | 1.7 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 | 0.9 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.0 | 3.2 | GO:0030509 | BMP signaling pathway(GO:0030509) |
| 0.0 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 0.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 1.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 1.9 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) |
| 0.0 | 0.5 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 | 1.4 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
| 0.0 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
| 0.0 | 1.4 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
| 0.0 | 0.5 | GO:1903513 | endoplasmic reticulum to cytosol transport(GO:1903513) |
| 0.0 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
| 0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 4.7 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 1.2 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.0 | 0.8 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.0 | 0.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 | 0.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 | 2.9 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.0 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 | 1.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 2.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.0 | 0.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.0 | 0.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 1.0 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 | 0.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.0 | 0.1 | GO:0071348 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
| 0.0 | 0.2 | GO:0007618 | mating(GO:0007618) |
| 0.0 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 4.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
| 0.0 | 1.2 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
| 0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.0 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.0 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 | 0.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
| 0.0 | 0.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 0.4 | GO:0001654 | eye development(GO:0001654) |
| 0.0 | 0.8 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 0.0 | 9.3 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.0 | 0.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.2 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 | 0.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 0.0 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.8 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.0 | 2.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.0 | 1.4 | GO:0061061 | muscle structure development(GO:0061061) |
| 0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 | 1.5 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.0 | 0.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.0 | 1.5 | GO:0007507 | heart development(GO:0007507) |
| 0.0 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 13.3 | GO:1990393 | 3M complex(GO:1990393) |
| 1.3 | 3.8 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 1.2 | 27.8 | GO:0005861 | troponin complex(GO:0005861) |
| 1.0 | 33.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.9 | 1.9 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.9 | 12.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.9 | 2.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.9 | 6.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.8 | 21.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.8 | 2.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.7 | 6.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.7 | 40.4 | GO:0031430 | M band(GO:0031430) |
| 0.7 | 8.3 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.7 | 4.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.7 | 3.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.6 | 1.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.5 | 9.2 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.5 | 6.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.5 | 4.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.5 | 5.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.5 | 7.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.4 | 4.9 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.4 | 1.3 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 0.4 | 13.1 | GO:0031672 | A band(GO:0031672) |
| 0.4 | 5.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.4 | 86.3 | GO:0030018 | Z disc(GO:0030018) |
| 0.4 | 10.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.4 | 8.9 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.4 | 17.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.4 | 2.4 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.4 | 1.1 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.4 | 6.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.4 | 2.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.3 | 11.5 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 5.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.3 | 0.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.3 | 2.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 1.2 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.3 | 2.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.3 | 11.5 | GO:0030017 | sarcomere(GO:0030017) |
| 0.2 | 9.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 11.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 2.1 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 9.9 | GO:0005605 | basal lamina(GO:0005605) |
| 0.2 | 6.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 2.2 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.2 | 0.8 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.2 | 1.0 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.2 | 0.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.2 | 1.5 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 6.1 | GO:0043218 | compact myelin(GO:0043218) |
| 0.2 | 2.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 2.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 2.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 3.0 | GO:0030016 | myofibril(GO:0030016) |
| 0.2 | 2.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.2 | 1.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 0.9 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.2 | 5.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 0.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) outer acrosomal membrane(GO:0002081) |
| 0.1 | 2.1 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 0.9 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 0.8 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 0.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.1 | 0.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.1 | 1.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 4.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 1.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 3.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 3.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 1.2 | GO:0072357 | glycogen granule(GO:0042587) PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 3.4 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 13.3 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 3.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 0.4 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.1 | 4.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 2.1 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 1.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 1.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 1.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 1.4 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.1 | 16.0 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 8.9 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 6.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 0.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.1 | 1.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 9.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 2.9 | GO:0012505 | endomembrane system(GO:0012505) |
| 0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.1 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 5.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 0.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 1.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 0.4 | GO:0042025 | host cell nucleus(GO:0042025) |
| 0.1 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 1.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.5 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 1.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 4.4 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 5.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
| 0.0 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 1.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 1.6 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 2.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 8.9 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.0 | 15.7 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.0 | 11.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 1.0 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
| 0.0 | 4.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 0.2 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 5.9 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 8.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.0 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 5.6 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 3.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 2.3 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.0 | 1.2 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.0 | 5.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.0 | 2.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
| 0.0 | 1.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 1.4 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 0.4 | GO:0097433 | dense body(GO:0097433) |
| 0.0 | 2.8 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 1.4 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.6 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 1.4 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.0 | 0.9 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 2.0 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 2.0 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 1.4 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 1.1 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.0 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.0 | 1.6 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.0 | 0.8 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 2.1 | GO:0044297 | cell body(GO:0044297) |
| 0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 6.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 0.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.0 | 3.2 | GO:0030425 | dendrite(GO:0030425) |
| 0.0 | 0.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 12.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 2.5 | 10.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 2.0 | 5.9 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.8 | 18.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.7 | 1.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 1.6 | 4.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 1.5 | 7.7 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 1.3 | 1.3 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 1.3 | 6.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 1.3 | 6.3 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.1 | 7.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 1.1 | 4.5 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 1.1 | 6.5 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 1.0 | 4.0 | GO:0051373 | FATZ binding(GO:0051373) |
| 1.0 | 2.0 | GO:0030172 | troponin C binding(GO:0030172) |
| 1.0 | 2.9 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 1.0 | 3.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.9 | 4.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.9 | 5.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.8 | 112.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.8 | 3.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.8 | 15.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.7 | 3.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.7 | 3.4 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 0.7 | 9.1 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.6 | 3.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.6 | 9.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.6 | 6.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.6 | 5.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.6 | 1.7 | GO:0030395 | lactose binding(GO:0030395) |
| 0.5 | 2.7 | GO:0033265 | acetylcholinesterase activity(GO:0003990) choline binding(GO:0033265) |
| 0.5 | 4.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.5 | 1.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.5 | 3.0 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.5 | 3.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.5 | 2.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.5 | 4.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.5 | 1.9 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.5 | 11.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 1.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.4 | 3.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.4 | 4.3 | GO:0031432 | titin binding(GO:0031432) |
| 0.4 | 3.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.4 | 3.8 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.4 | 7.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.4 | 6.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.4 | 13.1 | GO:0043495 | protein anchor(GO:0043495) |
| 0.4 | 3.3 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.4 | 2.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.4 | 1.6 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 0.4 | 8.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.4 | 4.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.4 | 3.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.4 | 4.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.4 | 3.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.3 | 1.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 1.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.3 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 5.1 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.3 | 8.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 4.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.3 | 1.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.3 | 2.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.3 | 3.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.3 | 1.5 | GO:0033906 | protein tyrosine kinase inhibitor activity(GO:0030292) hyaluronoglucuronidase activity(GO:0033906) |
| 0.3 | 4.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.3 | 1.4 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.3 | 1.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.3 | 2.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 1.1 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.3 | 3.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.3 | 2.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 17.0 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.3 | 3.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.3 | 1.8 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.2 | 3.0 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 1.0 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.2 | 6.1 | GO:0042166 | acetylcholine-gated cation channel activity(GO:0022848) acetylcholine binding(GO:0042166) |
| 0.2 | 4.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 2.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 5.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.2 | 1.2 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.2 | 4.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.2 | 5.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.2 | 0.7 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.2 | 3.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.2 | 7.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.2 | 0.6 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.2 | 4.8 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 12.2 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.2 | 0.8 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.2 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
| 0.2 | 4.8 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.2 | 4.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.2 | 3.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.2 | 2.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.2 | 1.0 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.2 | 0.3 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.2 | 0.6 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.2 | 7.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.2 | 1.6 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 0.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 1.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.2 | 1.5 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 2.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 1.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.2 | 0.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.2 | 5.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 1.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.1 | 4.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 5.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 2.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 2.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 0.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 1.8 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 1.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.1 | 1.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 3.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 1.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.1 | 0.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.1 | 0.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 4.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.1 | 19.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 2.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 2.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 1.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 1.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 1.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 3.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 8.9 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 6.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 1.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 0.9 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.1 | 2.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 1.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 2.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 1.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 2.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 0.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.1 | 1.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 2.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 2.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 4.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.4 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.4 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.1 | 0.3 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.1 | 1.8 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.1 | 1.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 6.9 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 0.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 0.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 3.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 1.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 0.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 2.3 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.1 | 0.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 1.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 7.7 | GO:0008270 | zinc ion binding(GO:0008270) |
| 0.1 | 3.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.1 | 1.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 1.7 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.1 | 0.5 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 3.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.9 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.1 | 5.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 2.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 5.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 0.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 2.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 1.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 2.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.1 | 1.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 0.5 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.1 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 5.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 1.2 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.1 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 2.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 2.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 1.2 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 9.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.1 | 10.4 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 0.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 5.0 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.1 | 17.0 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.1 | 2.6 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.1 | 0.4 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 0.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 10.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 1.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.1 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 4.8 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 1.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.0 | 0.1 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.0 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 1.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 7.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
| 0.0 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.0 | 8.2 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 1.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 2.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.0 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 0.3 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.0 | 4.0 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 1.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.0 | 0.5 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.0 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.0 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.0 | 1.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.6 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.5 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 2.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 1.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 1.1 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.2 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.0 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.0 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 1.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.0 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 14.0 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.2 | GO:0048037 | cofactor binding(GO:0048037) |
| 0.0 | 2.3 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.0 | 0.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 1.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.0 | 0.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.0 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.0 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 1.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 1.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.0 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 1.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 1.7 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.0 | 0.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.8 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.0 | 0.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.0 | 0.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 3.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 2.3 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
| 0.0 | 0.5 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 0.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 0.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 8.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.2 | 2.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 8.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 7.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 6.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 6.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 8.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 10.1 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 3.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 3.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 1.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 7.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 11.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 1.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 14.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 2.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 33.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 7.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 5.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 2.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 2.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 2.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 3.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 0.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 1.2 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 1.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 2.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 4.0 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 3.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 2.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 0.6 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 3.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 1.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 2.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 4.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 64.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.7 | 35.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.4 | 12.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.4 | 10.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 6.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.3 | 2.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 10.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 5.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.2 | 8.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.2 | 2.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 7.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 9.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 7.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 2.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 4.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 4.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.1 | 5.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 10.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 3.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 10.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 1.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 5.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 3.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 1.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 1.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 1.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.1 | 8.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 2.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 1.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.1 | 2.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 1.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 3.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 4.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 2.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 2.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.1 | 2.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 1.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 3.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 1.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.0 | 2.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.0 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.0 | 0.9 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.0 | 1.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 2.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 2.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.0 | 1.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 4.4 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.0 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 1.5 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 7.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.0 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.0 | 6.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 2.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 5.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 2.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.0 | 1.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.0 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 4.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 1.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 1.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 0.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 1.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |